Literature DB >> 14688544

Predicting and assessing visual performance with multizone bifocal contact lenses.

Joy A Martin1, Austin Roorda.   

Abstract

PURPOSE: To investigate how bifocal contact lenses, when combined with the aberrations of the eye, will affect visual performance. Also, to investigate the relationship between the patient's predicted and actual visual benefit with bifocal contact lenses.
METHODS: The monochromatic aberrations of 16 subjects were measured and used to simulate visual quality with three bifocal contact lens designs. Actual and computed visual benefit was compared for an Acuvue bifocal contact lens in 5 of the 16 subjects.
RESULTS: Subjects were predicted to have either a bifocal response or an increase in depth of focus for all lens designs. Our subjects were predicted to have a decrease in visual benefit for distance viewing and a gain in visual benefit at near compared with not wearing a contact lens. We found a statistically significant association between our subjects' predicted and actual visual benefit with the Acuvue Bifocal contact lens (r = 0.685, p = 0.008).
CONCLUSIONS: Bifocal contact lens designs, when combined with the aberrations of the eye, will not always provide bifocal vision. Visual quality with a bifocal contact lens can be predicted based on a patient's ocular aberrations.

Entities:  

Mesh:

Year:  2003        PMID: 14688544     DOI: 10.1097/00006324-200312000-00011

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  11 in total

1.  Effect of sampling on real ocular aberration measurements.

Authors:  Lourdes Llorente; Susana Marcos; Carlos Dorronsoro; Stephen A Burns
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2007-09       Impact factor: 2.129

2.  Accommodation in emmetropic and myopic young adults wearing bifocal soft contact lenses.

Authors:  Janice Tarrant; Holly Severson; Christine F Wildsoet
Journal:  Ophthalmic Physiol Opt       Date:  2008-01       Impact factor: 3.117

3.  The role of sensory ocular dominance on through-focus visual performance in monovision presbyopia corrections.

Authors:  Len Zheleznyak; Aixa Alarcon; Kevin C Dieter; Duje Tadin; Geunyoung Yoon
Journal:  J Vis       Date:  2015       Impact factor: 2.240

4.  Quantification of ghosting produced with presbyopic contact lens correction.

Authors:  Pete S Kollbaum; BoKaye M Dietmeier; Meredith E Jansen; Martin E Rickert
Journal:  Eye Contact Lens       Date:  2012-07       Impact factor: 2.018

5.  Integration of defocus by dual power Fresnel lenses inhibits myopia in the mammalian eye.

Authors:  Sally A McFadden; Dennis Y Tse; Hannah E Bowrey; Amelia J Leotta; Carly S Lam; Christine F Wildsoet; Chi-Ho To
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-14       Impact factor: 4.799

Review 6.  Adaptive optics for studying visual function: a comprehensive review.

Authors:  Austin Roorda
Journal:  J Vis       Date:  2011-06-16       Impact factor: 2.240

7.  Comparison of spherical aberration and small-pupil profiles in improving depth of focus for presbyopic corrections.

Authors:  Adam Hickenbotham; Pavan Tiruveedhula; Austin Roorda
Journal:  J Cataract Refract Surg       Date:  2012-09-30       Impact factor: 3.351

8.  Impact of contact lens zone geometry and ocular optics on bifocal retinal image quality.

Authors:  Arthur Bradley; Jayoung Nam; Renfeng Xu; Leslie Harman; Larry Thibos
Journal:  Ophthalmic Physiol Opt       Date:  2014-03-04       Impact factor: 3.117

9.  Modified monovision with spherical aberration to improve presbyopic through-focus visual performance.

Authors:  Len Zheleznyak; Ramkumar Sabesan; Je-Sun Oh; Scott MacRae; Geunyoung Yoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-03       Impact factor: 4.799

Review 10.  Bifocal and Multifocal Contact Lenses for Presbyopia and Myopia Control.

Authors:  Laura Remón; Pablo Pérez-Merino; Rute J Macedo-de-Araújo; Ana I Amorim-de-Sousa; José M González-Méijome
Journal:  J Ophthalmol       Date:  2020-03-27       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.